N/A
N=98
Medicinal Nicotine for Preventing Stress Induced Craving and Withdrawal Symptoms
Tobacco Use Disorder
Bottom Line
View on ClinicalTrials.gov: NCT01522963 ↗Enrolled (actual)
98
Serious AEs
0.0%
Results posted
Jul 2017
Primary outcome: Primary: Craving — 5.17; 2.45; -1.05; -1.34 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Nicotine lozenge (Drug)
- Age
- Adult, Older Adult · 18+ yrs
- Sex
- All
- Sponsor
- University of Minnesota
- Primary completion
- Jan 2014
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Craving |
5.17; 2.45; -1.05; -1.34 | — |
| PRIMARY Nicotine Withdrawal Symptoms |
2.1; 2.18; 0.32; 0.16 | — |
Summary
The purpose of this study is to determine the timeframe (relative to a stress task) that is most effective at attenuating the increase in symptoms of tobacco craving and withdrawal that occur when smokers are presented with stressful situations.
Eligibility Criteria
Inclusion Criteria
- Smoking an average of at least 10 cigarette per day
- General good health
Exclusion Criteria
- unstable medical or psychiatric conditions
- history of severe motion sickness
- women who are pregnant or breast feeding
The investigators will evaluate if there are other reasons why someone may not participate
Data sourced from ClinicalTrials.gov (NCT01522963). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.